Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A
Authors
Keywords
-
Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 21, Pages 15883-15911
Publisher
American Chemical Society (ACS)
Online
2021-10-27
DOI
10.1021/acs.jmedchem.1c01245
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS–SOS1 interaction
- (2019) Roman C. Hillig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PIP4K2A as a negative regulator of PI3K in PTEN-deficient glioblastoma
- (2019) Yong Jae Shin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Halogens in Protein–Ligand Binding Mechanism: A Structural Perspective
- (2019) Nicolas K. Shinada et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of BAY-298 and BAY-899: Tetrahydro-1,6-naphthyridine-Based, Potent, and Selective Antagonists of the Luteinizing Hormone Receptor Which Reduce Sex Hormone Levels in Vivo
- (2019) Lars Wortmann et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery and Characterization of the Potent and Selective P2X4 Inhibitor N-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction Profile
- (2019) Stefan Werner et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor
- (2019) Julien Lefranc et al. JOURNAL OF MEDICINAL CHEMISTRY
- Creation of a Novel Class of Potent and Selective MutT Homologue 1 (MTH1) Inhibitors Using Fragment-Based Screening and Structure-Based Drug Design
- (2018) Fredrik Rahm et al. JOURNAL OF MEDICINAL CHEMISTRY
- Donated chemical probes for open science
- (2018) Susanne Müller et al. eLife
- Discovery and Characterization of the Potent and Highly Selective (Piperidin-4-yl)pyrido[3,2-d]pyrimidine Based in Vitro Probe BAY-885 for the Kinase ERK5
- (2018) Duy Nguyen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains
- (2017) Léa Bouché et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dual blockade of the lipid kinase PIP4Ks and mitotic pathways leads to cancer-selective lethality
- (2017) Mayumi Kitagawa et al. Nature Communications
- Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876
- (2016) Holger Siebeneicher et al. ChemMedChem
- Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2
- (2016) Erik Eggert et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel TIE-2 inhibitor BAY-826 displaysin vivoefficacy in experimental syngeneic murine glioma models
- (2016) Hannah Schneider et al. JOURNAL OF NEUROCHEMISTRY
- PIP4K and the role of nuclear phosphoinositides in tumour suppression
- (2015) Roberta Fiume et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Potent and Selective Human Neutrophil Elastase Inhibitors with Novel Equatorial Ring Topology: in vivo Efficacy of the Polar Pyrimidopyridazine BAY-8040 in a Pulmonary Arterial Hypertension Rat Model
- (2015) Franz von Nussbaum et al. ChemMedChem
- The promise and peril of chemical probes
- (2015) Cheryl H Arrowsmith et al. Nature Chemical Biology
- Hitting cancers’ weak spots: vulnerabilities imposed by p53 mutation
- (2015) Evrim Gurpinar et al. TRENDS IN CELL BIOLOGY
- Protein–ligand interactions investigated by thermal shift assays (TSA) and dual polarization interferometry (DPI)
- (2015) Morten K. Grøftehauge et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- A targeted knockdown screen of genes coding for phosphoinositide modulators identifies PIP4K2A as required for acute myeloid leukemia cell proliferation and survival
- (2014) J G Jude et al. ONCOGENE
- Depletion of a Putatively Druggable Class of Phosphatidylinositol Kinases Inhibits Growth of p53-Null Tumors
- (2013) Brooke M. Emerling et al. CELL
- Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
- (2013) D. M. Molina et al. SCIENCE
- PtdIns5P is an oxidative stress-induced second messenger that regulates PKB activation
- (2012) David R. Jones et al. FASEB JOURNAL
- Preclinical Pharmacology of AZD5363, an Inhibitor of AKT: Pharmacodynamics, Antitumor Activity, and Correlation of Monotherapy Activity with Genetic Background
- (2012) B. R. Davies et al. MOLECULAR CANCER THERAPEUTICS
- Overview of theCCP4 suite and current developments
- (2011) Martyn D. Winn et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
- (2010) Jonathan B. Baell et al. JOURNAL OF MEDICINAL CHEMISTRY
- PtdIns5P protects Akt from dephosphorylation through PP2A inhibition
- (2009) Damien Ramel et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- AKT and Oxidative Stress Team Up to Kill Cancer Cells
- (2008) Ignacio Dolado et al. CANCER CELL
- Akt Determines Replicative Senescence and Oxidative or Oncogenic Premature Senescence and Sensitizes Cells to Oxidative Apoptosis
- (2008) Veronique Nogueira et al. CANCER CELL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started